Starting treatment with agonist replacement therapy: Should I join?
This brochure, intended for participants thinking about joining the CTN-0027 clinical trial (Starting Treatment with Agonist Replacement Therapies), answers questions about who can participate and what happens if you join, and provides information about the medication used in the project, buprenorphine naloxone (Suboxone).
Related protocols: CTN-0027
Categories:
Buprenorphine/Naloxone, Community health services, Liver enzymes, Opioid dependence, Participant information, Pharmacological therapy, Suboxone
Authors :
NIDA Center for the Clinical Trials Network (NIDA CCTN)
Source :
Bethesda, MD: National Institute on Drug Abuse, 2006